Nigel Langley of gChem stresses excipient innovation, safer solvents, and supply chain resilience for pharma’s future in part ...

AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, ...

Pharmaceutical Technology® spoke with Peter Freed, head of Global Pharma CTS, Roquette, about a variety of materials-related ...

Maggie Saykali, Cefic, emphasizes the importance of competitiveness and innovation for European manufacturers to create added ...

Nigel Langley of gChem discusses the company’s DMSO, proactive pharma strategies, and more in part 1 of a 2-part interview ...

As Thermo Fisher’s Jennifer Cannon explains in this first part of a two-part interview, the collaboration is intended to help improve the speed and success of drug development.

ACG showcased the expansion of its European presence, and Bora Pharmaceuticals participates in a discussion about CDMO ...

React4Life’s Silvia Scaglione emphasizes how organ-on-chip tech and AI are reshaping drug testing, personalized treatment, ...

Eva-Maria Hempe, NVIDIA, says AI collaboration optimizes life science research via routine automation, freeing human experts for complex strategy, ethics, and exploring scarce data.

Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective ...

Patient adherence is improving thanks to technologies that offer a more personalized experience, deepening the connection ...